Expert Interview: Ulcerative Colitis (UC)

Therapeutic options for UC have advanced over the past decade. In this interview, Dr. med. Michel Maillard talks about this evolution, highlighting personalized care strategies and ongoing challenges in optimizing long‑term outcomes. 1-3

VV-MEDMAT-133546

References

  • 1. Turner D, et al. "STRIDE-II: An Update on Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target Strategies in IBD." Gastroenterology. 2021;160(5):1570–1583.

  • 2. D’Amico F, et al. "Personalized Medicine in Ulcerative Colitis: From Bench to Bedside."
    World J Gastroenterol. 2021;27(22):3081–3096.

  • 3. Raine T, et al. "ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment." Journal of Crohn's and Colitis. 2022;16(1):2-17.